It has been well documented that abnormally overexpression of ADORA1 can facilitate the malignant progressions of colon cancer 13, kidney cancer 14, breast cancer 15, glioblastoma 16 and leukemia 17. This evidence concerns the gene ADORA1 and breast cancer.